Verismo Therapeutics, Inc. — Form D

Verismo Therapeutics, Inc. of Philadelphia, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-14. $19.2M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2023-07-14
• Form: D
• Accession: 0001855431-23-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Amount sold: $19.2M
• Investors: 7
• Date of first sale: 2023-07-07
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-487001

Issuer

• Name: Verismo Therapeutics, Inc.
• CIK: 0001855431
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 3675 Market Street, Suite 200, Philadelphia, PA, 19104
• Phone: 609-790-5188

Officers, directors & promoters (9)

Other filings by this issuer (2)

More

• CIK 1855431 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search